Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
Status:
Terminated
Trial end date:
2014-11-12
Target enrollment:
Participant gender:
Summary
Currently medications injected intravitreally in previously vitrectomized eyes have a very
short half-life due to enhanced clearance of the drug. The use of the Ozurdex (dexamethasone)
implant may allow sustained levels of steroid delivery to patients with diabetic macular
edema that have undergone prior vitrectomy. The sustained steroid levels may lead to improved
central retinal thickness measurements and improved visual acuity.